Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 7;14(6):1798.
doi: 10.3390/jcm14061798.

Assessment of Safety and Efficacy of Expanded Hemodialysis with Medium Cut-Off Dialyzer Compared to Haemodiafiltration

Affiliations

Assessment of Safety and Efficacy of Expanded Hemodialysis with Medium Cut-Off Dialyzer Compared to Haemodiafiltration

Matteo Marcello et al. J Clin Med. .

Abstract

Background: Removal of large uraemic toxins is still a challenge. Haemodiafiltration (HDF) has produced some results, although large convective volume, optimal vascular access to increase the blood flow rate and strict water quality management are required. Medium cut-off, high-retention-onset membranes have been recently developed, introducing the concept therapy called expanded haemodialysis (HDx). Furthermore, vitamin E-coated membrane has potential beneficial effects on inflammation and oxidative stress. Methods: A prospective longitudinal multicentre study was conducted for 3 months among 24 chronic haemodialysis patients. Patients were randomly assigned into either HDF with high-flux membrane or HDx with Theranova or ViE-X membrane. The primary goal was to assess albumin loss among the three types of dialyzers. Secondary goals included assessment of depurative efficacy for uraemic toxins and clinical outcomes. Results: Mean albumin loss was significantly higher in patients undergoing HDx with Theranova membrane, without any difference in serum albumin concentration among the three groups. Instantaneous clearance of small and middle molecules was significantly higher in patients undergoing HDF, but we did not find differences in removal ratio and Kt/V. Reduction in the erythropoietin resistance index was observed in patients treated with ViE-X membrane due to their lower dialysis vintage. Conclusions: The higher albumin loss during HDx has no effects on pre-dialysis serum albumin. HDx with Theranova in the presence of lower session length, lower Qb, lower convective dose, and lower instantaneous clearance reached the same dialysis efficacy compared to HDF.

Keywords: expanded haemodialysis; haemodiafiltration; medium cut-off; middle molecules.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest. Claudio Ronco in the last three years has been a consultant, medical advisor, or part of the speaker bureau receiving fees from the following companies: Asahi Medical, Aferetica, Baxter, B.Braun, Biomerieux, Bioporto, Cytosorbents, ESTOR, Fresenius Medical Care, GE Healthcare, Kaneka, Medica, Medtronic- Bellco, Nipro, Spectral, Toray, and Jafron.

Figures

Figure 1
Figure 1
Serum albumin at different timepoints. Timepoint 0 refers to the first observation, and subsequent timepoints (1–3) refer to month from the first observation.

References

    1. Locatelli F., Gauly A., Czekalski S., Hannedouche T., Jacobson S.H., Loureiro A., Martin-Malo A., Papadimitriou M., Passlick-Deetjen J., Ronco C., et al. The MPO Study: Just a European HEMO Study or something very different? Blood Purif. 2008;26:100–104. doi: 10.1159/000110574. - DOI - PubMed
    1. Kuragano T., Kida A., Furuta M., Nanami M., Otaki Y., Hasuike Y., Nonoguchi H., Nakanishi T. The impact of beta2-microglobulin clearance on the risk factors of cardiovascular disease in hemodialysis patients. ASAIO J. 2010;56:326–332. doi: 10.1097/MAT.0b013e3181de0842. - DOI - PubMed
    1. Nakano T., Matsui M., Inoue I., Awata T., Katayama S., Murakoshi T. Free immunoglobulin light chain: Its biology and implications in diseases. Clin. Chim. Acta. 2011;412:843–849. doi: 10.1016/j.cca.2011.03.007. - DOI - PubMed
    1. Ronco C. The Rise of Expanded Hemodialysis. Blood Purif. 2017;44:I–VIII. doi: 10.1159/000476012. - DOI - PubMed
    1. Sakurai K. Biomarkers for evaluation of clinical outcomes of hemodiafiltration. Blood Purif. 2013;35((Suppl. 1)):64–68. doi: 10.1159/000346364. - DOI - PubMed

LinkOut - more resources